We’re still trying to understand the impact of the COVID-19 pandemic on cancer services. So, it’s important to build a detailed picture of how patients have been affected.
Men can also get breast cancer. It’s rare, but around 370 are diagnosed with the disease every year in the UK. It’s important we the differences between breast cancer in men and women so we can find better ways to prevent and treat the disease.
Around 15% of breast cancer are classed as triple negative. This form of breast cancer currently has limited targeted treatments available. So, we need to find new and effective ways to treat people diagnosed with triple negative breast cancer.
In these blogs, we explore some of the biggest topics in breast cancer research. One of those topics is how the body’s biological clock is involved in breast cancer.
To celebrate our research successes of the past year our research communications officer, Edd, picked out his favourite discoveries and explains why they are so important.
Scientists, based at the Queen Mary University of London, have discovered a new mechanism that signals which Ductal Carcinoma in Situ (DCIS) tumours may progress to invasive breast cancer. This might help avoid unnecessary treatment for some women with DCIS in the future.